Select Medical (NYSE:SEM) Stock Passes Above Two Hundred Day Moving Average – What’s Next?

Shares of Select Medical Holdings Corporation (NYSE:SEM) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $15.70 and traded as high as $16.56. Select Medical shares last traded at $16.5350, with a volume of 465,583 shares trading hands.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on SEM shares. Wall Street Zen downgraded Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, March 9th. Royal Bank Of Canada restated a “sector perform” rating and issued a $16.50 price objective (down from $19.00) on shares of Select Medical in a research report on Tuesday, March 3rd. Weiss Ratings raised Select Medical from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday. Mizuho reaffirmed a “neutral” rating and issued a $16.50 price target (down from $17.00) on shares of Select Medical in a research note on Tuesday, May 12th. Finally, Benchmark lowered Select Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, March 4th. One investment analyst has rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, Select Medical presently has a consensus rating of “Hold” and an average price target of $15.50.

Select Medical Stock Up 0.3%

The business has a 50 day moving average of $16.44 and a 200-day moving average of $15.70. The stock has a market cap of $2.05 billion, a PE ratio of 15.60, a P/E/G ratio of 0.95 and a beta of 1.01. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.88.

Select Medical (NYSE:SEM) last posted its quarterly earnings data on Thursday, April 30th. The health services provider reported $0.36 earnings per share for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.07). The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.41 billion. Select Medical had a return on equity of 6.62% and a net margin of 2.42%.The firm’s revenue was up 5.0% compared to the same quarter last year. During the same period in the previous year, the business posted $0.44 earnings per share. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Equities research analysts predict that Select Medical Holdings Corporation will post 1.26 EPS for the current fiscal year.

Select Medical Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, May 28th. Shareholders of record on Thursday, May 14th were given a dividend of $0.0625 per share. The ex-dividend date of this dividend was Thursday, May 14th. This represents a $0.25 annualized dividend and a yield of 1.5%. Select Medical’s dividend payout ratio (DPR) is presently 23.58%.

Select Medical declared that its board has authorized a stock repurchase program on Thursday, February 19th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the health services provider to reacquire up to 49.5% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s board believes its stock is undervalued.

Hedge Funds Weigh In On Select Medical

Several hedge funds have recently bought and sold shares of SEM. Royal Bank of Canada grew its position in shares of Select Medical by 8.5% in the first quarter. Royal Bank of Canada now owns 95,771 shares of the health services provider’s stock valued at $1,599,000 after purchasing an additional 7,502 shares during the period. AQR Capital Management LLC lifted its stake in shares of Select Medical by 96.6% in the first quarter. AQR Capital Management LLC now owns 33,894 shares of the health services provider’s stock worth $566,000 after acquiring an additional 16,656 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Select Medical by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 64,400 shares of the health services provider’s stock valued at $1,075,000 after buying an additional 2,809 shares in the last quarter. Dynamic Technology Lab Private Ltd acquired a new stake in Select Medical during the first quarter valued at approximately $220,000. Finally, Goldman Sachs Group Inc. raised its stake in Select Medical by 25.3% during the first quarter. Goldman Sachs Group Inc. now owns 728,689 shares of the health services provider’s stock valued at $12,169,000 after buying an additional 147,183 shares in the last quarter. Hedge funds and other institutional investors own 89.48% of the company’s stock.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.